Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129,337,627
-
Total 13F shares
-
311,346
-
Share change
-
+56,853
-
Total reported value
-
$1,182,680
-
Put/Call ratio
-
54%
-
Price per share
-
$3.79
-
Number of holders
-
9
-
Value change
-
+$252,483
-
Number of buys
-
4
-
Number of sells
-
4
Institutional Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2020
As of 30 Jun 2020,
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
311,346 shares.
The largest 9 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Federation des caisses Desjardins du Quebec, NORTHERN TRUST CORP, Tower Research Capital LLC (TRC), UBS Group AG, GROUP ONE TRADING, L.P., and BlackRock Inc..
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.